October 20, 2018
November 15, 2018
Tentative Program Download Scientific Program
IPSEN, France
Allergan Inc.CA, USA
GE HealthcareUT, USA
Director Peptide Discovery, Novartis Institutes
SartoriusFrance
Innotech Management Solutions, Canada
LIDDS ABSweden
BioAgilytixGermany
NovartisAustria
Pion Inc (UK) Limited, UK
Pharma Consultant Services, AL, USA
Martin Luther University Halle-Wittenberg, Germany
INSERMFrance
Northeastern University, MA, USA
Pennington Biomedical Research Center, LA, USA
Vanderbilt University, TN, USA
University of Miami Miller School of Medicine, FL, USA
University of Mississippi Medical Center, MS, USA
University of Rochester Medical Center, NY, USA
Rutgers University, NJ, USA
University of Nebraska College of Pharmacy, NE, USA
Texas Tech University Health Sciences Center, TX, USA
Auburn University, AL, USA
Ghent University, Belgium
University of Reading, UK
University of Nottingham, UK
University of Sunderland, UK
National Medical Research Center for Cardiology, Russia
University of Turin, Italy
Escuela Nacional de Ciencias Biológicas-IPN, Mexico
Saudi Food and Drug Authority, Saudi Arabia
King Faisal Specialist Hospital & Research Centre, Saudi Arabia
Euroved, Germany
CEU-Cardenal Herrera University, Spain
Hamad Medical Cooperation, Qatar
University of Zimbabwe, Zimbabwe
Retired Doctor, Slovenia
King Abdulaziz Medical City, Saudi Arabia
Gomal UniversityPakistan
West Virginia University, WV, USA
Federal University of Pernambuco, Brazil
Chandigarh UniversityIndia
PD Science LLC, USA
Federal University of Rio Grande do Sul - UFRGS, Brazil
Federal University of São Paulo, Brazil
Sunchon National University, South Korea
University of Campania “Luigi Vanvitelli”, Italy
Chiang Mai University, Thailand
Ain Shams University, Egypt
